A Phase I Pharmacokinetics Study for KT07 Capsule

Clinical trial NCT05223660 · COMPLETED

Trial details

NCT number: NCT05223660
Sponsor: Yiling Pharmaceutical Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects Pharmacokinetics Safety and Tolerability

Start date: 2022-01-07
Primary completion: 2022-07-20
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.